ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia.

Jie Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.